Nanovibronix Inc (NAOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 752 | 3,283 | 2,713 | 7,737 | 7,533 |
| Receivables | 98 | 318 | 9 | 200 | 292 |
| Inventories | 2,191 | 2,732 | 2,175 | 175 | 145 |
| TOTAL | $3,331 | $6,487 | $5,609 | $8,342 | $7,970 |
| Non-Current Assets | |||||
| PPE Net | 9 | 7 | 7 | 5 | 4 |
| Other Non-Current Assets | 289 | 180 | 263 | 275 | 255 |
| TOTAL | $298 | $187 | $270 | $280 | $259 |
| Total Assets | $3,629 | $6,674 | $5,879 | $8,622 | $8,229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,655 | 2,403 | 2,214 | 1,810 | 632 |
| Other current liabilities | N/A | N/A | N/A | N/A | 2,257 |
| TOTAL | $2,722 | $2,454 | $2,316 | $1,903 | $2,902 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15 | 46 | 21 | 44 | N/A |
| Other Non-Current Liabilities | 280 | 217 | 223 | 253 | 2,734 |
| TOTAL | $280 | $232 | $330 | $406 | $2,933 |
| Total Liabilities | $3,002 | $2,686 | $2,646 | $2,309 | $5,835 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76 | 25 | 15 | 13 | 11 |
| Common Shares | 3 | 2 | 2 | 1 | 22 |
| Retained earnings | -69,801 | -66,096 | -62,385 | -56,937 | -42,655 |
| Other shareholders' equity | -80 | -67 | -18 | 60 | 66 |
| TOTAL | $627 | $3,988 | $3,233 | $6,313 | $2,394 |
| Total Liabilities And Equity | $3,629 | $6,674 | $5,879 | $8,622 | $8,229 |